Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up

被引:4
作者
Tang, Jiyang [1 ,2 ,3 ,4 ]
Han, Xinyao [1 ,2 ,3 ,4 ]
Tang, Ran [1 ,2 ,3 ,4 ]
Li, Mengyang [1 ,2 ,3 ,4 ]
Wang, Zongyi [1 ,2 ,3 ,4 ]
Zhao, Mingwei [1 ,2 ,3 ,4 ]
Qu, Jinfeng [1 ,2 ,3 ,4 ]
机构
[1] Peking Univ Peoples Hosp, Dept Ophthalmol, 11 Xizhimen South St, Beijing 100044, Peoples R China
[2] Eye Dis & Optometry Inst, Beijing, Peoples R China
[3] Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China
[4] Peking Univ, Hlth Sci Ctr, Coll Optometry, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
Pachychoroid; Pachychoroid pigment epitheliopathy; Polypoidal choroidal vasculopathy; Pachychoroid spectrum diseases; NEOVASCULARIZATION; ANGIOGRAPHY;
D O I
10.1186/s12886-022-02487-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Pachychoroid pigment epitheliopathy (PPE), a retinal disorder that falls into the pachychoroid spectrum, is characterized by retinal pigment epithelium changes in pachychoroid eyes without existing or previous subretinal fluid or soft drusen. Previous reports have indicated that PPE may share some pathophysiologic component with other pachychoroid spectrum diseases and could transform into central serous chorioretinopathy (CSC) during follow-up. CSC transformation to PNV and PCV has also been reported, but PPE transformation to PCV has not been reported. Case presentation Seven eyes of seven patients (four male three female, aged 62.7 +/- 8.4 years) who presented with PPE at baseline transformed to PCV during follow-up. All study eyes had baseline contralateral eye diagnoses of PCV. All PPE eyes reported no symptoms at baseline and were followed up regularly for the treatment of their contralateral eyes. All PPE presented as pigment epithelium detachment (PED) at baseline. The mean central macular thickness (CMT) was 217.6 +/- 14.6 mu m, the mean subfoveal choroidal thickness (SFCT) was 354.9 +/- 94.9 mu m, and the mean sub-PPE choroidal thickness was 332.3 +/- 84.6 mu m. The mean PPE width and height were 1326.4 +/- 791.4 mu m and 58.7 +/- 23.6 mu m, respectively, at baseline. Disruption of the ellipsoid zone (EZ) was noted in 3 eyes, while choroidal vascular hyperpermeability (CVH) was noted in 5 eyes at baseline. The follow-up period was 75.0 +/- 41.1 months, and the mean transformation time was 49.6 +/- 24.8 months. All study eyes received no intervention before transformation. Conclusions PPE could transform to PCV after a long follow-up period. Regular follow-ups for a long time should be recommended for patients with PPE.
引用
收藏
页数:9
相关论文
共 50 条
[31]   Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy [J].
M Inoue ;
A Arakawa ;
S Yamane ;
K Kadonosono .
Eye, 2013, 27 :1013-1021
[32]   Long-term outcomes of polypoidal choroidal vasculopathy in comparison with typical exudative age-related macular degeneration [J].
Hyeon Cheol Roh ;
Sang Jin Kim ;
Se Woong Kang ;
Jun Soo Eun ;
Kyung Jun Choi .
Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 :83-92
[33]   Long-Term Follow-Up of an Atypical Case of Idiopathic Macular Telangiectasia [J].
Mucciolo, Dario Pasquale ;
Murro, Vittoria ;
Sodi, Andrea ;
Virgili, Gianni ;
Rizzo, Stanislao .
OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2018, 49 (12) :E278-E283
[34]   Long-term outcomes of polypoidal choroidal vasculopathy in comparison with typical exudative age-related macular degeneration [J].
Roh, Hyeon Cheol ;
Kim, Sang Jin ;
Kang, Se Woong ;
Eun, Jun Soo ;
Choi, Kyung Jun .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (01) :83-92
[35]   Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy [J].
Jae Hui Kim ;
Jong Woo Kim ;
Chul Gu Kim ;
Dong Won Lee .
Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 :1677-1685
[36]   Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy [J].
Zhi-Xi Li ;
Yi-Jun Hu ;
Alp Atik ;
Lin Lu ;
Jie Hu .
International Journal of Ophthalmology, 2019, (12) :1859-1864
[37]   Long-term angiographic follow-up is mandatory after endovascular treatment of aneurysms [J].
Raymond, J ;
Georganos, SA ;
Guilbert, F ;
Lambert, A ;
Lamoureux, J ;
Weill, A ;
Roy, D .
RIVISTA DI NEURORADIOLOGIA, 2003, 16 (06) :1175-1176
[38]   Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy [J].
Kim, Jae Hui ;
Kim, Jong Woo ;
Kim, Chul Gu ;
Lee, Dong Won .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) :1677-1685
[39]   Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy [J].
Li, Zhi-Xi ;
Hu, Yi-Jun ;
Atik, Alp ;
Lu, Lin ;
Hu, Jie .
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2019, 12 (12) :1859-1864
[40]   Comparison of visual outcomes of polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration-up to 10 years of follow-up [J].
Park, Jun Young ;
Park, Young Joo ;
Park, Sang Jun ;
Park, Kyu Hyung ;
Yeo, Joon Hyung ;
Kim, June-Gone ;
Yoon, Young Hee ;
Lee, Joo Yong ;
Woo, Se Joon .
ACTA OPHTHALMOLOGICA, 2022, 100 (08) :E1579-E1588